Pharmaceuticals

News | Antiplatelet and Anticoagulation Therapies | November 16, 2017

November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes...

News | Heart Failure | November 13, 2017

November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop...

Six Months of DAPT Non-Inferior to Twelve in STEMI Patients Receiving Drug-Eluting Stents
News | Antiplatelet and Anticoagulation Therapies | November 06, 2017

November 6, 2017 —  The first trial to evaluate the safety of...

Synergy Stent With Shorter DAPT Superior to Bare-Metal Stent in Elderly Patients
News | Stents Drug Eluting | November 06, 2017

November 6, 2017 — Elderly patients undergoing...

Statins Attributed With 10-Year Cholesterol Drop for Malaysian Heart Attack Patients
News | Antiplatelet and Anticoagulation Therapies | November 03, 2017

November 3, 2017 — A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests...

Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual Therapy Stent

Image courtesy of OrbusNeich

News | Stents Drug Eluting | November 01, 2017

November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at...

FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents | October 27, 2017

October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved...

News | Stem Cell Therapies | October 24, 2017

October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate...

Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017

October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...

News | Pharmaceuticals | October 04, 2017

October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated...

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure | September 19, 2017

September 19, 2017 — The heart failure...

News | Pharmaceuticals | September 12, 2017

September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in...

New FOURIER Analysis Examines How Low Cholesterol Can Safely Go
News | ESC | September 12, 2017

September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with...

CANTOS Study Shows Reducing Inflammation Cuts Cardiovascular Disease, Lung Cancer Risk
News | ESC | September 12, 2017

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk...

COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with...

Overlay Init